Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Labgene Biotech Co., Ltd. is a specialized molecular diagnostics company that develops and manufactures integrated systems for clinical testing and life science research. Founded in 2011 and based in Guangzhou, China, the company provides a comprehensive portfolio including automated nucleic acid extraction instruments, real-time PCR thermal cyclers, and a wide array of reagent kits. Their diagnostic solutions focus on high-growth areas such as infectious disease monitoring, oncology-related genetic testing, and personalized medicine. Labgene Biotech serves a diverse range of medical institutions, third-party testing laboratories, and academic research centers globally. The company is publicly traded on the National Equities Exchange and Quotations (NEEQ) and is recognized for its vertical integration of hardware and biochemical reagent development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labgene Biotech.